You can buy or sell PLx Pharma and other stocks, options, ETFs, and crypto commission-free!
PLx Pharma Inc. Common Stock, also called PLx Pharma, is a late-stage specialty pharmaceutical company, which engages in the development of clinically validated and patent-protected PLxGuard delivery system. Read More Its products include Vazalore 325 mg and PL1200 Ibuprofen 200 mg. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Houston, TX.
52 Week High
52 Week Low
Stock Price, News, & Analysis for PLx Pharma
Press coverage about PLXP stock has trended somewhat positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. PLx Pharma earned a daily sentiment score of 2.0 on InfoTrie's scale. They also assigned news articles about the biotech...
Seeking AlphaMar 8
PLx Pharma's (PLXP) CEO Natasha Giordano on Q4 2018 Results - Earnings Call Transcript
PLx Pharma's (NASDAQ:PLXP) Q4 2018 Earnings Conference Call March 8, 2019 8:30 AM ET Company Participants Lisa Wilson - IR, In Site Communications Natasha Giordano - President and Chief Executive Officer Rita O'Connor - Chief Financial Officer Conference Call Participants Operator Good day ladies and gentlemen and welcome to PLx Pharma Inc. Fourth Quarter 2018 Results Conference Call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session, instruc...
Expected May 10, Pre-Market